Artico Ice

Description

The product is identified by the SPL code 34089-3. No specific description details are provided in the text.

Uses and Indications

This drug is indicated for use in patients as determined by the prescribing healthcare professional. Currently, there are no specific indications or usage details provided.

There are no known teratogenic or nonteratogenic effects associated with this drug. Healthcare professionals should consider the absence of these effects when evaluating treatment options for their patients.

Dosage and Administration

Gel Del Artico is a cool, greaseless pain reliever designed for the temporary relief of minor aches and pains in muscles and joints.

For administration, the gel should be applied directly to the affected area as needed to achieve relief. It is important to ensure that the skin is clean and dry prior to application. The gel penetrates deeply into the skin, providing fast relief from discomfort.

Contraindications

There are no specific contraindications listed for this product. However, it is essential to keep the product out of reach of children to prevent accidental ingestion or misuse.

Warnings and Precautions

For external use only, this product is not intended for internal application. It is imperative to use the product strictly as directed, ensuring that it does not come into contact with the eyes or mucous membranes. Application to open wounds or damaged skin is contraindicated. Prior to application, the skin must be clean and devoid of any creams, ointments, sprays, or liniments. Bandaging the area post-application is not recommended.

The use of heating pads or any heating devices in conjunction with this product is prohibited. Should the condition worsen or if symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, it is essential to discontinue use and seek medical advice.

Individuals with sensitive skin are advised to consult a physician prior to use. In the event of skin irritation, the product should be discontinued immediately, and medical consultation should be sought.

Pregnant or nursing individuals must consult their healthcare provider before using this product.

Additionally, it is critical to avoid using, storing, pouring, or spilling the product near heat sources or open flames. The product should be stored in a cool, dry environment with the lid securely closed to maintain its integrity.

Side Effects

Patients using this product should be aware of several important warnings and precautions. The product is intended for external use only and should not be applied internally. Care should be taken to avoid contact with the eyes or mucous membranes, and it should not be applied to open wounds or damaged skin. Prior to application, the skin must be clean and free from any creams, ointments, sprays, or liniments.

It is advised not to bandage the area after application, nor should the product be used in conjunction with heating pads or other heating devices. If a patient's condition worsens or symptoms persist for more than 7 days, or if symptoms disappear and then recur within a few days, the use of the product should be discontinued, and a physician should be consulted.

Patients with sensitive skin are encouraged to consult a physician before using the product. In the event that skin irritation develops, the product should be discontinued immediately, and medical advice should be sought. Additionally, pregnant or nursing patients should consult their doctor prior to use.

The product should be stored in a cool, dry place, with the lid tightly closed, and must not be used, stored, poured, or spilled near heat or open flame.

Drug Interactions

The use of this medication is contraindicated with heating pads or heating devices, as the combination may lead to adverse effects. It is essential to avoid such interactions to ensure patient safety and the efficacy of the treatment.

Regarding laboratory test interactions, there are no specific interactions identified. Therefore, routine laboratory tests can be conducted without concern for interference from this medication. However, standard clinical judgment should always be applied when interpreting test results in the context of the patient's overall treatment plan.

Packaging & NDC

Below are the non-prescription pack sizes of Artico Ice (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this product out of reach of children to prevent accidental ingestion or misuse. For children with sensitive skin, it is recommended to consult a physician prior to use to ensure safety and appropriateness of the product.

Geriatric Use

There is no specific information available regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy.

Pregnancy

Pregnant patients and those who are nursing should consult their healthcare provider prior to using this medication. It is essential to evaluate the potential risks and benefits associated with the use of this drug during pregnancy and lactation. The prescribing physician can provide guidance based on individual circumstances and the latest clinical data.

Lactation

Lactating mothers are advised to consult their doctor prior to using this medication. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, healthcare professionals should consider the potential risks and benefits when recommending this medication to nursing mothers.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring of these patients.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide the management of the overdose effectively.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for appropriate treatment and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the compound in these areas.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children to prevent accidental ingestion or misuse. It is important to emphasize the necessity of proper storage to ensure the safety of young individuals.

Storage and Handling

The product is supplied in a secure container that must be stored in a cool, dry place to maintain its integrity. It is essential to keep the lid tightly closed when not in use to prevent contamination and degradation. Additionally, the product should not be used, stored, poured, or spilled near heat sources or open flames to ensure safety and efficacy.

Additional Clinical Information

The product is intended for topical administration only. Patients should be advised that it is for external use only and must not be applied internally. It is crucial to avoid contact with eyes or mucous membranes and to refrain from applying it to open wounds or damaged skin. The skin should be clean and free from any other topical products prior to application, and the area should not be bandaged.

Patients should not use the product in conjunction with heating pads or heating devices. If the condition worsens or symptoms persist beyond 7 days, or if symptoms resolve and then recur within a few days, they should discontinue use and consult a physician. Individuals with sensitive skin are encouraged to seek medical advice before use. In cases of skin irritation, use should be discontinued, and a physician should be consulted. Pregnant or nursing patients should also consult their doctor prior to use. The product should be stored in a cool, dry place, away from heat or open flame, with the lid tightly closed.

Drug Information (PDF)

This file contains official product information for Artico Ice, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)